We are looking forward to host Professor Juliana Idoyaga from University of California, San Diego for LIT seminar.
Her lab is driven by one central question: how do dendritic cells (DCs) – the immune system’s decision-makers – control lymphocyte responses?
To tackle this, they combine high-resolution -omics technologies, in vivo models, and clinically relevant therapies to study human and mouse DCs side by side, along with their close relatives—monocytes and macrophages. This integrative strategy enables them to define the distinct molecular programs that set DCs apart within the broader immune landscape. Her work spans five key areas: (1) the origins and functions of emerging DC subsets; (2) how DC gene programs are regulated; (3) how DCs specialize in different tissues; (4) the roles DCs play in human immune responses; and (5) how cancer therapies reshape DC function. By understanding how DCs develop, adapt, and act compared to monocytes and macrophages, the goal is to turn these insights into precise, personalized, and effective DC-based immune therapies.
When: Friday, November 20th at 15:00. Fika will be available from 14:30, courtesy of Stem Cell Technologies.
Where: Segerfalksalen, BMC A10
















Comments